• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Albemarle confirms non-binding agreement to acquire Liontown

    9/3/23 8:20:00 PM ET
    $ALB
    Major Chemicals
    Industrials
    Get the next $ALB alert in real time by email

    Liontown board intends to recommend revised proposal to its shareholders, subject to entry into a binding agreement and other terms and conditions

    CHARLOTTE, N.C., Sept. 3, 2023 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today confirmed that it will be working toward the execution of a binding agreement to acquire Liontown Resources Limited ("Liontown").

    Albemarle Corp. Logo. (PRNewsFoto/Albemarle Corporation)

    Albemarle notes the announcement to the ASX by Liontown today and confirms that it submitted a best and final non-binding proposal, in the absence of a superior proposal, to acquire all outstanding shares of Liontown by way of scheme of arrangement for A$3.001 cash per share ("Revised Proposal"). The Revised Proposal values Liontown at A$6.6 billion or US$4.32 billion on an equity value basis.

    The Revised Proposal is subject to several conditions, including:

    - Satisfactory completion of confirmatory due diligence by Albemarle;

    - Entry into a binding scheme implementation deed (SID) that will be subject to closing conditions, including obtaining Australian regulatory approvals and Liontown shareholder approval; and

    - Final Albemarle board approval to enter into the proposed transaction on a binding basis.

    The Revised Proposal delivers an immediate premium for Liontown investors and is expected to drive significant value creation for Albemarle shareholders. The transaction is consistent with Albemarle's long-term growth and stated M&A strategy, as well as its disciplined approach to capital allocation and risk-adjusted value accretion. The Revised Proposal was unanimously approved by Albemarle's Board of Directors.

    Pending successful due diligence and negotiation of a binding SID, the proposed acquisition of Liontown would:

    - Enhance the scale of Albemarle's industry-leading Energy Storage business and build on Albemarle's world-class resource base

    - Expand Albemarle's strong position in Australia, where the Company has significant expertise, including world-class spodumene resources and lithium conversion facilities at Greenbushes and Wodgina and Kemerton, respectively

    - Increase opportunity to meet rapidly growing lithium demand driven by electric vehicles and other end markets

    - Allow Albemarle to maintain a strong balance sheet with expected net leverage of approximately 1.2x3

    The Liontown Board has confirmed to Albemarle that, subject to entry into a mutually acceptable non-disclosure and exclusivity agreement, it intends to grant Albemarle an opportunity to conduct a limited period of exclusive due diligence, subject to customary fiduciary exceptions, to enable it to put forward a binding proposal. Should Albemarle make a binding proposal at $3.00 per share, the Liontown Board intends to unanimously recommend that Liontown shareholders vote in favor of the Revised Proposal, in the absence of a superior proposal, and subject to the parties entering into a mutually acceptable binding SID, the completion of Albemarle's due diligence to Albemarle's satisfaction, and an independent expert concluding (and continuing to conclude) that the Revised Proposal is in the best interests of Liontown shareholders.

    Albemarle and Liontown will enter into a mutually acceptable non-disclosure and exclusivity agreement granting Albemarle with an exclusivity period to undertake confirmatory due diligence and negotiate a binding SID.

    The Revised Proposal is non-binding and there is no certainty that any transaction will be agreed to or will proceed.

    Albemarle's capital allocation priorities remain investing in high-return organic and inorganic growth, maintaining its financial flexibility and investment grade credit rating, and funding its dividends.

    With relation to the transaction, Albemarle has engaged J.P. Morgan as lead financial advisor, with Barrenjoey also serving as financial advisor. Corrs Chambers Westgarth and Shearman & Sterling LLP are serving as legal advisors.

    Webcast

    The company will hold a webcast to discuss the Revised Proposal on Tuesday, September 5 from 7:00 to 7:30 a.m. EDT. The webcast will be accessible at the time of the event through the Events and Presentations page on Albemarle's website at http://investors.albemarle.com. A webcast replay will be posted to the company's website immediately following the conclusion of the event.

    A copy of the presentation will be posted to the company's Investor Relations section of its website at http://investors.albemarle.com. 

    About Albemarle

    Albemarle Corporation (NYSE:ALB) is a global leader in transforming essential resources into critical ingredients for mobility, energy, connectivity, and health. Together with our world-class lithium and bromine resources, technical and process knowledge, and safety and sustainability performance, we partner with our customers to pioneer new ways to move, power, connect, and protect. We are committed to building a more resilient world where people and planet thrive. Learn more about Albemarle at www.albemarle.com and at @albemarlecorp on LinkedIn, Twitter, and Facebook.

    Albemarle regularly posts information to its website, including notification of events, news, financial performance, investor presentations and webcasts, non-GAAP reconciliations, SEC filings and other information regarding the company, its businesses, and the markets it serves. Albemarle Corporation (NYSE:ALB) is a global leader in transforming essential resources such as lithium and bromine into critical ingredients for mobility, energy, connectivity, and health. Together with our world-class resources, technical and process knowledge, and safety and sustainability performance, we partner with our customers to pioneer new ways to move, power, connect, and protect. We are committed to building a more resilient world where people and planet thrive. Learn more about Albemarle at www.albemarle.com and at @albemarlecorp on LinkedIn, Twitter, and Facebook.

    Forward-Looking Statements

    This press release contains statements concerning our expectations, anticipations, and beliefs regarding the future, which constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, which are based on assumptions that we have made as of the date hereof and are subject to known and unknown risks and uncertainties, often contain words such as "anticipate," "believe," "estimate," "expect," "guidance," "intend," "may," "outlook," "should," "would," and "will". Forward-looking statements may include statements regarding expected: outcomes of discussions between Albemarle and Liontown with respect to the proposed transaction, terms of the proposed transaction, benefits to Albemarle from the proposed transaction, and all other information relating to matters that are not historical facts. Factors that could cause Albemarle's actual results to differ materially from the outlook expressed or implied in any forward-looking statement include: Albemarle and Liontown not agreeing to pursue the transaction on the currently proposed terms or at all, risks associated with Albemarle's and Liontown's ability to obtain required approvals of the proposed transaction, the outcome of due diligence and satisfaction of other customary closing conditions, the possibility that costs or difficulties related to the integration of Liontown's operations will be greater than expected, the outcome of any legal proceedings that may be instituted against Albemarle or Liontown related to the proposed transaction, and the other factors detailed in the reports Albemarle files with the SEC, including those described under "Risk Factors" in Albemarle's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are available on the investor section of Albemarle's website (investors.albemarle.com) and on the SEC's website (www.sec.gov). These forward-looking statements speak only as of the date of this press release. Albemarle assumes no obligation to provide any revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.

    1 Equivalent to US$1.94 cash per share based on an AUD/USD exchange rate of 0.6456 as at September 1, 2023

    2 Based on an AUD/USD exchange rate of 0.6456 as at September 1, 2023

    3 Based on Albemarle's balance sheet and trailing-twelve month adjusted EBITDA as of June 30, 2023

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/albemarle-confirms-non-binding-agreement-to-acquire-liontown-301916561.html

    SOURCE Albemarle Corporation

    Get the next $ALB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALB

    DatePrice TargetRatingAnalyst
    1/21/2026$205.00Hold → Buy
    Truist
    1/20/2026$200.00Hold → Buy
    HSBC Securities
    1/13/2026$185.00Hold → Buy
    Deutsche Bank
    1/12/2026$200.00Sector Perform → Sector Outperform
    Scotiabank
    1/7/2026$210.00Neutral → Outperform
    Robert W. Baird
    12/16/2025$147.00Underweight → Equal-Weight
    Morgan Stanley
    12/5/2025$185.00Neutral → Buy
    UBS
    12/2/2025$113.00Underperform → Neutral
    Robert W. Baird
    More analyst ratings

    $ALB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman & CEO Masters J Kent covered exercise/tax liability with 27,459 shares, decreasing direct ownership by 19% to 118,853 units (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    1/2/26 4:13:08 PM ET
    $ALB
    Major Chemicals
    Industrials

    Chief Financial Officer Sheorey Neal Ravi covered exercise/tax liability with 854 shares and converted options into 1,953 shares, increasing direct ownership by 10% to 12,210 units (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    11/10/25 4:13:38 PM ET
    $ALB
    Major Chemicals
    Industrials

    General Counsel & Sec Krupa Ander C. sold $18,060 worth of shares (172 units at $105.00), decreasing direct ownership by 1% to 11,483 units (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    10/28/25 4:17:35 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Coleman Kristin M. bought $167,314 worth of shares (1,373 units at $121.86) (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    11/7/23 4:39:49 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Albemarle upgraded by Truist with a new price target

    Truist upgraded Albemarle from Hold to Buy and set a new price target of $205.00

    1/21/26 8:25:13 AM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded Albemarle from Hold to Buy and set a new price target of $200.00

    1/20/26 8:06:42 AM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Albemarle from Hold to Buy and set a new price target of $185.00

    1/13/26 8:40:16 AM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $ALB
    SEC Filings

    View All

    Albemarle Announces Plans to Idle its Kemerton Lithium Hydroxide Processing Plant

    Decision improves financial flexibility and preserves optionality CHARLOTTE, N.C., Feb. 11, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced it will idle the remaining operating train, Train 1, at its Kemerton lithium hydroxide processing plant in Western Australia and place it into care and maintenance effective immediately. Today's announcement follows actions in 2024 to place Train 2 into care and maintenance and to cease expansion plans for Trains 3 and 4.

    2/11/26 4:20:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Reports Fourth Quarter and Full Year 2025 Results

    CHARLOTTE, N.C., Feb. 11, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Full Year 2025 Results and Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Fourth quarter net sales of $1.4 billion, up 16%; volume up 12%, including gains in all segments led by Energy Storage (up 17%) and Ketjen (up 13%).Fourth quarter net loss of

    2/11/26 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Lithium Reclaims Its Role as a Critical Growth Metal as Miners Ramp Up Operations in 2026

    NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Lithium demand is picking up real momentum as electric vehicles and energy storage continue to scale globally. EVs remain the biggest driver, but what's changing the story is how quickly battery storage for power grids, renewables, and data centers is growing. As governments and utilities push for more reliable, low-carbon power, lithium-based batteries are becoming essential infrastructure. Industry forecasts continue to point to lithium demand more than doubling by the end of the decade, with 2026 shaping up as a key inflection year where demand growth clearly outpaces new supply. Active Companies the marke

    1/15/26 8:45:00 AM ET
    $ALB
    $LAC
    $SLI
    Major Chemicals
    Industrials
    Metal Mining
    Basic Materials

    SEC Form 10-K filed by Albemarle Corporation

    10-K - ALBEMARLE CORP (0000915913) (Filer)

    2/11/26 4:49:08 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - ALBEMARLE CORP (0000915913) (Filer)

    2/11/26 4:23:21 PM ET
    $ALB
    Major Chemicals
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Albemarle Corporation

    SCHEDULE 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    1/29/26 11:23:22 AM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Financials

    Live finance-specific insights

    View All

    Albemarle Announces Plans to Idle its Kemerton Lithium Hydroxide Processing Plant

    Decision improves financial flexibility and preserves optionality CHARLOTTE, N.C., Feb. 11, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced it will idle the remaining operating train, Train 1, at its Kemerton lithium hydroxide processing plant in Western Australia and place it into care and maintenance effective immediately. Today's announcement follows actions in 2024 to place Train 2 into care and maintenance and to cease expansion plans for Trains 3 and 4.

    2/11/26 4:20:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Reports Fourth Quarter and Full Year 2025 Results

    CHARLOTTE, N.C., Feb. 11, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Full Year 2025 Results and Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Fourth quarter net sales of $1.4 billion, up 16%; volume up 12%, including gains in all segments led by Energy Storage (up 17%) and Ketjen (up 13%).Fourth quarter net loss of

    2/11/26 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Corporation to Release Fourth Quarter 2025 Earnings Results on Wednesday, February 11, 2026

    CHARLOTTE, N.C., Jan. 13, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, announced today that it will release its fourth quarter 2025 earnings after the NYSE closes on Wednesday, February 11, 2026. The company will hold a conference call to discuss its fourth quarter 2025 results on Thursday, February 12, at 8 a.m. EST. Access to the call is available via webcast or direct dial. A link to the webcast can be found through Albemarle Corporation's website at http://investors.alb

    1/13/26 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Leadership Updates

    Live Leadership Updates

    View All

    Ketjen Announces the Appointment of Henri Tausch as Chief Commercial Officer

    Ketjen Corporation, a leader in catalyst and specialty chemicals manufacturing, today announces the appointment of Henri Tausch to Chief Commercial Officer (CCO) effective June 24, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240619765799/en/Henri Tausch, Ketjen Chief Commercial Officer (Photo: Business Wire) In his role as Chief Commercial Officer, Tausch will oversee and advance the company's commercial strategy, and foster key partnerships to accelerate the company's global growth trajectory. "I am honored to join Ketjen and contribute to its continued success," said Henri Tausch "It's inspiring to see Ketjen's dedi

    6/19/24 7:00:00 AM ET
    $ALB
    Major Chemicals
    Industrials

    International Paper Announces Changes to Its Board of Directors

     Jamie A. Beggs and Scott A. Tozier to Join as Newest Board Members Ilene S. Gordon to Retire from the Board MEMPHIS, Tenn., May 22, 2024 /PRNewswire/ -- International Paper ("IP") (NYSE:IP) announced that Jamie A. Beggs and Scott A. Tozier have been elected to IP's Board of Directors, effective May 21, 2024. The company also announced that Ilene S. Gordon has retired from the Board citing personal and health reasons, effective May 21, 2024. Ms. Beggs, age 47, currently serves as Senior Vice President and Chief Financial Officer of Avient Corporation (NYSE:AVNT), a premier pr

    5/23/24 10:51:00 AM ET
    $ALB
    $AVNT
    $IP
    Major Chemicals
    Industrials
    Paper
    Basic Materials

    Albemarle Reports Net Sales Increase of 60% for Second Quarter 2023

    CHARLOTTE, N.C., Aug. 2, 2023 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the second quarter ended June 30, 2023. Second-Quarter 2023 and Recent Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Net sales of $2.4 billion, an increase of 60%Net income of $650.0 million, or $5.52 per diluted share, an increase of 60%Adjusted diluted EPS of $7.33, an increase of 112%Adjusted EBITDA of $1.0 billion, an i

    8/2/23 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

    SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    12/5/24 7:27:01 PM ET
    $ALB
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by Albemarle Corporation

    SC 13G - ALBEMARLE CORP (0000915913) (Subject)

    11/13/24 12:52:42 PM ET
    $ALB
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

    SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    11/13/24 10:27:59 AM ET
    $ALB
    Major Chemicals
    Industrials